UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000038296
Receipt No. R000043525
Scientific Title Clinical Benefits of Following Therapy after Anti-HER2 Standard Therapy for HER2-positive, Unresectable and/or Metastatic Breast Cancer: a Retrospective Registry Study (KBCSG-TR 1917)
Date of disclosure of the study information 2019/10/15
Last modified on 2020/06/16 09:35:20

No. Disposal Last modified on Item of update
1 Insert 2019/10/15 16:35:38
2 Update 2020/01/29 11:01:30 Org. issuing International ID_1
3 Update 2020/01/29 11:03:04 Recruitment status
Date of closure to data entry
Date trial data considered complete
4 Update 2020/01/30 09:44:17 Number of participants that the trial has enrolled
5 Update 2020/06/16 09:35:20 Recruitment status

Contact us.